Lifeline Cell Technology Expands Asian Distribution Network
July 16, 2014
CARLSBAD, CA -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based biotechnology company focused on therapeutic and research products, today announced that its subsidiary, Lifeline Cell Technology, has expanded its sales network by adding a number of new distributors in Asia and Oceania. "Expanding our footprint in the fast-growing Asian [...]
RainDance Technologies Appoints Kathy Ordonez to Board of Directors
July 16, 2014
BILLERICA, Mass. — — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Kathy Ordoñez to its Board of Directors. Kathy Ordoñez brings more than 30 years of experience in the life sciences and diagnostics industries. As Senior Vice President at Quest Diagnostics, Ms. Ordonez [...]
Illumina Acquires Myraqa, a Leading IVD and Companion Diagnostic Consulting Firm
July 16, 2014
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Myraqa, a regulatory and quality consulting firm specializing in IVDs, particularly companion diagnostics. Led by founder and CEO Mya Thomae, Myraqa focuses on regulatory strategy and application support, including PMAs, pre-submissions, IDEs, 510(k)s, de novo 510(k)s, and EU technical files. The acquisition will [...]
Phenomenex Announces Spin-Off of a Technology Start-up Company–Neoteryx LLC
July 16, 2014
Torrance, CA -- Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, revealed it will be spinning off a biological sampling focused company named Neoteryx LLC. The name Neoteryx is derived from the word neoteric, meaning new or modern, and conveys the new start-up’s mission to deliver [...]
Beckman Coulter to Acquire Siemens Healthcare Diagnostics’ Clinical Microbiology Business
July 16, 2014
BREA, CALIF. –– Beckman Coulter, an indirect wholly-owned subsidiary of Danaher Corporation (NYSE:DHR), announced today that it has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics. The Siemens clinical microbiology business is an established leader in microbial identification and antibiotic sensitivity testing (ID/AST). The business operates with an [...]
BellBrook Labs Develops a TR-FRET Based Transcreener GTPase Assay
July 16, 2014
BellBrook Labs announced the launch of a new Transcreener GDP Assay with a TR-FRET (time resolved Forster resonance energy transfer) readout, for sensitive detection of hundreds of enzymes of potential therapeutic interest including the large GTPase family as well as glycosyltransferase enzymes that use GDP-activated sugars; e.g., fucosyltransferases. These and related enzymes are being targeted [...]
LOPHIUS BIOSCIENCES LAUNCHES ITS NOVEL T CELL TOOLS PRODUCT LINE AND ONLINE ORDER PORTAL
July 16, 2014
Regensburg, Germany -– Lophius Biosciences GmbH, a privately held biotech company focusing on the development and marketing of innovative T cell based research tools and diagnostic systems for functional assessment of pathogen/disease-reactive T cells, today announced the launch of its new T CELL TOOLS product line together with its new e-commerce online order portal. The [...]
July 16, 2014
SAN DIEGO, SEOUL, South Korea and MELBOURNE, Australia -- BioNano Genomics announced today the selection of two new distributors, MDxK and Millennium Science, for the IrysTM System in the Asia-Pacific region. Based in Seoul, MDxK is one of the premier life science instrumentation distributors for Korea and has already sold the first system to ChunLab. [...]
Celsion Corporation Announces Commercialization of Reagent Products
July 15, 2014
LAWRENCEVILLE, N.J. -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced initiation of sales of its proprietary reagent products for life science research. Celsion's reagent products are based on its newly acquired proprietary delivery platform technologies, TheraPlas™ and TheraSilence™. TheraPlas™ and TheraSilence™ are designed for optimal transfection (intra-cellular delivery) of plasmid [...]
RAN BIOTECHNOLOGIES ANNOUNCES DISTRIBUTORSHIP AGREEMENT WITH FLUIGENT
July 15, 2014
BEVERLY, Mass. -- RAN Biotechnologies, https://www.ranbiotechnologies.com, a provider of chemicals and solutions specially optimized for biotechnological applications, has entered into a distributorship agreement with Fluigent, https://www.fluigent.com, a Paris-based leader in microfluidic flow control instruments, for distribution of RAN Biotechnologies products in Europe. “We are very excited to be distributing the products of RAN Biotechnologies,” said [...]

